Holder snapshot 7 signals
Share change
+1,321,837
Put/Call ratio
100%
SEC-reported price per share
$9.06
Number of holders
106
Value change
+$11,702,533
Number of buys
44
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
52,046,621

Security key

G8807B106

Report period

Q2 2022

Institutions

106

Top holders

10

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAUPOST GROUP LLC/MA
Disclosed value leader
BAUPOST GROUP LLC/MA
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 26% Showing 1-6 of 15 holder rows.

Quick read

BAUPOST GROUP LLC/MA leads the comparable SEC ownership view at 26%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAUPOST GROUP LLC/MA's linked filing trail.
Comparable ownership Top 5
BAUPOST GROUP LLC/MA 26%
Madison Avenue Partners, LP 14%
VANGUARD GROUP INC 13%
Weiss Asset Management LP 10%
BlackRock Finance, Inc. 9.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAUPOST GROUP LLC/MA
13F
Company
13F
26%
$130,430,000
13,643,333 shares
31 Mar 2022
Madison Avenue Partners, LP
13F
Company
13F
14%
$69,497,223
7,269,584 shares
31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
13%
$66,421,000
6,947,947 shares
31 Mar 2022
Weiss Asset Management LP
13F
Company
13F
10%
$51,743,000
5,412,487 shares
31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
9.5%
$47,123,000
4,929,140 shares
31 Mar 2022
ORBIMED ADVISORS LLC
13F
Company
13F
6.3%
$31,115,000
3,254,713 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
106
Shares
64,209,180
Rows available
106
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
114
Q2 2022 holders
106
Holder diff
-8
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .